Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.03 - $5.32 $781,982 - $1.37 Million
-258,080 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$16.94 - $19.89 $4.37 Million - $5.13 Million
258,080 New
258,080 $5.51 Million

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Antara Capital LP Portfolio

Follow Antara Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Antara Capital LP with notifications on news.